U.S. FDA Calls for Citizen Input on Descheduling Cannabis

FDA opens comments re descheduling of cannabis

In January of 2019, WHO recommended the rescheduling of cannabis. The U.S. is preparing to address rescheduling of cannabis at the upcoming United Nations Commission on Narcotic Drugs (CND) meeting.

The U.S. Food and Drug Administration Agency has opened up a short comment period intended to bring the public’s voice into their decision process. Lowell J. Schiller, Acting Associate Commissioner for Policy, posted Feb 25, 2019 a request for those interested in submitting comments about the World Health Organization (WHO) recommendations.

Presumably, your comments are meant to inform U.S. policy ahead of the March 18-22 meeting of the United Nations CND in Vienna, Austria. Electronic comments must be submitted on or before March 14, 2019.

If interested in commenting, please visit Regulations.gov.

Related Posts

by
Previous Post Next Post

Leave a Reply

Your email address will not be published.

Cannabis News Highlights
Get Free Weekly News

Subscribe and get the best cannabis news of the week delivered directly to you.

Thank you for subscribing.

Something went wrong.

Share This